Sign in
Taking people in South AfricaNo phase

Gene Activity Profiles in Adults With Spinal Tuberculosis

Compares blood gene activity in adults with spinal tuberculosis, with or without spread.

Key facts

Who runs it
University of Cape Town
Where
Cape Town, South AfricaSee the site
Trial code
Registry title
Gene Expression Profiles in Spinal Tuberculosis.
Status
Recruiting
People taking part
100 people, planned
Started
25 Oct 2022
Expected to end
31 Dec 2026
Type of study
Observational
Record updated
23 August 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with tuberculosis of the spine (TB spine). It compares gene activity in people whose TB stays in the spine with people whose TB has spread to other organs.

Age
18 years or older, and a body weight of at least 40 kg (88 lb).
Sex
All sexes can join.
Disease stage
TB of the spine, based on clinical and radiological criteria.

Main reasons for not taking part

  • Pregnancy, or wanting to become pregnant within the next 6 months
  • Uncontrolled diabetes
  • Alcohol or substance abuse that might interfere with taking medication during the trial
  • Positive SARS-CoV-2 PCR test in the past 4 weeks
  • Known or suspected cancer on MRI, or suspected inflammatory or rheumatological disease

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Participant has completed the written informed consent process prior to undergoing any clinical evaluations and willing to undergo HIV testing
  • TB spine based on clinical and radiological criteria
  • Age 18 or older with a body weight of at least 40 kg body weight
  • Able and willing to return to follow-up
  • Willing to have samples, including DNA including RNA extraction, stored
  • Willing to consistently practice a highly reliable method of pregnancy prevention

Who cannot take part

  • Alcohol and substance abuse which might interfere with medication adherence during the trial
  • Suspicion of malignancy on MRI or known malignancy
  • Suspicion of inflammatory disease and other rheumatological conditions
  • Uncontrolled diabetes (HbA1c ≥ 6.5% / random glucose concentration ≥11.1 mmol/l, fasting plasma glucose ≥ 7.0 mmol/l)
  • Pregnancy or active desire to become pregnant within the next 6 months
  • Positive SARS-CoV-2 PCR in the past 4 weeks
  • Any person for whom the physician feels this study is not appropriate

This trial is currently available in South Africa.

  • Groote Schuur HospitalCape Town, South AfricaContact: Julian F Scherer, MDTaking people

About the trial

What the trial wants to find out

Tuberculosis (TB) is one of the top ten causes of death worldwide with approximately 10 million cases globally and 1.2 million deaths. Sub-Saharan Africa carries the highest burden of TB. South Africa has one of the highest HIV and TB rates worldwide with an HIV prevalence rate in adults of 19% and a TB case notification rate of 615/100,000 in 2019. Over many years, focus has been paid to pulmonary TB and extrapulmonary TB (EPTB) has received only little attention even though it accounts for almost a quatre of all TB cases. The diagnosis of EPTB remains challenging simply because sample collection requires invasive procedures in the absence of a blood-based diagnostic test. Spinal TB (spondylitis or spondylodiscitis caused by Mycobacterium tuberculosis) - often known as Pott's disease - accounts for up to 10% of EPTB and affects young children, people with HIV-coinfection and elderly, and often leads to lifelong debilitating disease due to devastating deformation of the spine and compression of neural structures. Little is known with regards to the extent of disease and isolated TB spine as well as a disseminated form of TB spine have been described. The latter presents with a spinal manifestation plus disseminations to other organs such as the lungs, pleura, lymph nodes, the GIT or urinary tract or even the brain.

Read full original descriptionShow less

In the Spinal TB X cohort, the investigators aim to describe the clinical phenotype of spinal TB using whole body PET/CT and identify a specific gene expression profile for the different stages of dissemination and compare findings to previously described signatures for latent and active pulmonary TB. A blood-based test for spinal TB would lead to earlier diagnosis and treatment in all settings globally and improve treatment outcome of this devastating disease.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparing Gene Expression Profiles of Adults With Isolated Spinal TB to Disseminated Spinal TB Identified by 18FDG-PET/CT at Time of Diagnosis, 6-and 12-months Follow-up
Plain-language title
Gene Activity Profiles in Adults With Spinal TuberculosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
23 August 2024